{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:38:42Z","timestamp":1790789922920,"version":"4.1.0"},"reference-count":52,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053190","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T22:41:19Z","timestamp":1359067279000},"page":"e53190","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":98,"title":["FLT3 Mutations in Early T-Cell Precursor ALL Characterize a Stem Cell Like Leukemia and Imply the Clinical Use of Tyrosine Kinase Inhibitors"],"prefix":"10.1371","volume":"8","author":[{"given":"Martin","family":"Neumann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Coskun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Fransecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana H.","family":"Mochmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Farhadi Sartangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Heesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"G\u00f6kbuget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Brandts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelia","family":"Schlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"D\u00fchrsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Griesshammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"D\u00f6hner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Burmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Thiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"Hoelzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolf-Karsten","family":"Hofmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia D.","family":"Baldus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia","volume":"1","author":"AA Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL)","volume":"106","author":"J Soulier","year":"2005","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The recurrent SET-NUP214 fusion as a new HOXA activation mechanism in pediatric T-cell acute lymphoblastic leukemia","volume":"111","author":"P van Vlierberghe","year":"2008","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-cell precursor leukaemia: a subtype of very high-risk acute lymphoblastic leukaemia","volume":"10","author":"E Coustan-Smith","year":"2009","journal-title":"Lancet Oncol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2012.02.013","article-title":"TLX Homeodomain Oncogenes Mediate T Cell Maturation Arrest in T-ALL via Interaction with ETS1 and Suppression of TCRalpha Gene Expression","volume":"21","author":"S Dadi","year":"2012","journal-title":"Cancer Cell"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"J Zhang","year":"2012","journal-title":"Nature"},{"key":"ref7","article-title":"Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia","author":"M Paganin","year":"2010","journal-title":"Blood Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.leu.2404957","article-title":"Prognostic significance of molecular-cytogenetic abnormalities in pediatric T-ALL is not explained by immunophenotypic differences","volume":"22","author":"M van Grotel","year":"2008","journal-title":"Leukemia"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"AP Weng","year":"2004","journal-title":"Science"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","article-title":"Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia","volume":"108","author":"S Breit","year":"2006","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1182\/blood-2008-10-184069","article-title":"NOTCH1\/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study","volume":"113","author":"V Asnafi","year":"2009","journal-title":"Blood"},{"key":"ref12","article-title":"The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia","author":"L Zuurbier","year":"2012","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia","volume":"6","author":"C Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3324\/haematol.2009.011999","article-title":"Regulation of PTEN by CK2 and Notch1 in primary T-cell acute lymphoblastic leukemia: rationale for combined use of CK2- and gamma-secretase inhibitors","volume":"95","author":"A Silva","year":"2010","journal-title":"Haematologica"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-01-0168","article-title":"Activating FLT3 mutations in CD117\/KIT(+) T-cell acute lymphoblastic leukemias","volume":"104","author":"E Paietta","year":"2004","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1182\/blood-2005-06-2267","article-title":"Activating FLT3 mutations in CD4+\/CD8- pediatric T-cell acute lymphoblastic leukemias","volume":"106","author":"P van Vlierberghe","year":"2005","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1309\/AJCPR3N3JMSYLPFG","article-title":"CD117 expression is a sensitive but nonspecific predictor of FLT3 mutation in T acute lymphoblastic leukemia and T\/myeloid acute leukemia","volume":"137","author":"D Hoehn","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/sj.leu.2403099","article-title":"FLT3: ITDoes matter in leukemia","volume":"17","author":"M Levis","year":"2003","journal-title":"Leukemia"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1200\/JCO.2010.30.2554","article-title":"Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications","volume":"29","author":"G Marcucci","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/CCO.0b013e32833118fd","article-title":"FLT3 inhibition as a targeted therapy for acute myeloid leukemia","volume":"21","author":"M Sanz","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1002\/cncr.25908","article-title":"FLT3 inhibitors in the treatment of acute myeloid leukemia: the start of an era?","volume":"117","author":"N Pemmaraju","year":"2011","journal-title":"Cancer"},{"key":"ref22","article-title":"Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutations","volume":"e55","author":"M Neumann","year":"2012","journal-title":"Blood Cancer Journal"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1182\/blood-2005-07-2708","article-title":"Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia","volume":"107","author":"M Bruggemann","year":"2006","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1200\/JCO.2007.11.5253","article-title":"Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome","volume":"25","author":"CD Baldus","year":"2007","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3324\/haematol.2009.016386","article-title":"Prognostic implications of mutations and expression of the Wilms tumor 1 (WT1) gene in adult acute T-lymphoblastic leukemia","volume":"95","author":"S Heesch","year":"2010","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/leu.2010.130","article-title":"BAALC-associated gene expression profiles define IGFBP7 as a novel molecular marker in acute leukemia","volume":"24","author":"S Heesch","year":"2010","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2006-04-014845","article-title":"High meningioma 1 (MN1) expression as a predictor for poor outcome in acute myeloid leukemia with normal cytogenetics","volume":"108","author":"M Heuser","year":"2006","journal-title":"Blood"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","article-title":"Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling","volume":"23","author":"AP Weng","year":"2003","journal-title":"Mol Cell Biol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3324\/haematol.2008.005272","article-title":"Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia","volume":"94","author":"CD Baldus","year":"2009","journal-title":"Haematologica"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"e38463","DOI":"10.1371\/journal.pone.0038463","article-title":"High accuracy mutation detection in leukemia on a selected panel of cancer genes","volume":"7","author":"AZ Kalender","year":"2012","journal-title":"PLoS One"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1158\/0008-5472.CAN-05-0422","article-title":"Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation","volume":"65","author":"CH Brandts","year":"2005","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia","volume":"19","author":"I Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1084\/jem.20090934","article-title":"GATA-3 is required for early T lineage progenitor development","volume":"206","author":"T Hosoya","year":"2009","journal-title":"J Exp Med"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coi.2011.12.012","article-title":"Transcriptional drivers of the T-cell lineage program","volume":"24","author":"EV Rothenberg","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1242\/dev.126.14.3131","article-title":"Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage","volume":"126","author":"MK Anderson","year":"1999","journal-title":"Development"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.beha.2010.08.001","article-title":"Surrogate marker profiles for genetic lesions in acute leukemias","volume":"23","author":"E Paietta","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-1\/Flk2) in human leukemias","volume":"87","author":"CE Carow","year":"1996","journal-title":"Blood"},{"key":"ref38","article-title":"Prognostic significance of FLT3 mutational status and expression levels in MLL-AF4+ and MLL-germline acute lymphoblastic leukemia","author":"MC Chillon","year":"2012","journal-title":"Leukemia"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2141.2011.08955.x","article-title":"Clinical significance of early T-cell precursor acute lymphoblastic leukaemia: results of the Tokyo Children's Cancer Study Group Study L99-15","volume":"156","author":"T Inukai","year":"2012","journal-title":"Br J Haematol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1182\/blood-2003-02-0359","article-title":"BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study","volume":"102","author":"CD Baldus","year":"2003","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1200\/JCO.2007.15.2058","article-title":"Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study","volume":"26","author":"P Paschka","year":"2008","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Y Yamamoto","year":"2001","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood.V93.9.3033","article-title":"TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation","volume":"93","author":"B Blom","year":"1999","journal-title":"Blood"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1084\/jem.20042524","article-title":"New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling","volume":"201","author":"WA Dik","year":"2005","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1182\/blood.V82.11.3283.3283","article-title":"Human primitive hematopoietic progenitor cells are more enriched in KITlow cells than in KIThigh cells","volume":"82","author":"Y Gunji","year":"1993","journal-title":"Blood"},{"key":"ref46","first-page":"392","article-title":"CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype","volume":"83","author":"N Cascavilla","year":"1998","journal-title":"Haematologica"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V78.11.2962.2962","article-title":"Expression and functional role of the proto-oncogene c-kit in acute myeloblastic leukemia cells","volume":"78","author":"H Ikeda","year":"1991","journal-title":"Blood"},{"key":"ref48","first-page":"258","article-title":"AML: immunophenotypic heterogeneity and prognostic significance of c-kit expression","volume":"8","author":"MA Reuss-Borst","year":"1994","journal-title":"Leukemia"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"3816","DOI":"10.1200\/JCO.2010.28.3390","article-title":"Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemia","volume":"28","author":"A Gutierrez","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1182\/asheducation-2006.1.133","article-title":"Treatment of adult acute lymphoblastic leukemia","author":"N Gokbuget","year":"2006","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1200\/JCO.2009.25.4888","article-title":"Phase I\/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia","volume":"28","author":"F Ravandi","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/blood-2009-09-242859","article-title":"FLT3-mutant allelic burden and clinical status are predictive of response to FLT3 inhibitors in AML","volume":"115","author":"KW Pratz","year":"2010","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T19:24:52Z","timestamp":1644175492000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053190"}},"subtitle":[],"editor":[{"given":"Kristy L.","family":"Richards","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053190","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}